285 related articles for article (PubMed ID: 17448941)
1. Cutaneous leishmaniasis treatment.
Minodier P; Parola P
Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
[TBL] [Abstract][Full Text] [Related]
2. Treatment of New World cutaneous and mucosal leishmaniases.
Berman JD
Clin Dermatol; 1996; 14(5):519-22. PubMed ID: 8889330
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
Wijnant GJ; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607026
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
[TBL] [Abstract][Full Text] [Related]
5. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of localized cutaneous leishmaniasis].
Buffet P; Caumes E; Gentilini M
Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
[No Abstract] [Full Text] [Related]
7. Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission.
Oliveira-Neto MP; Schubach A; Mattos M; da Costa SC; Pirmez C
Int J Dermatol; 1997 Jun; 36(6):463-8. PubMed ID: 9248897
[TBL] [Abstract][Full Text] [Related]
8. [The therapy of cutaneous and mucocutaneous leishmaniasis].
Blum J; Hatz C; Junghanss T
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1169-72. PubMed ID: 8076505
[No Abstract] [Full Text] [Related]
9. Leishmaniasis.
Herwaldt BL
Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
[TBL] [Abstract][Full Text] [Related]
10. Occlusive paromomycin for cutaneous leishmaniasis.
Bell SA; Schaller M; Röcken M
Lancet; 1997 Jan; 349(9044):29. PubMed ID: 8988124
[No Abstract] [Full Text] [Related]
11. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
Soto J; Fuya P; Herrera R; Berman J
Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
[TBL] [Abstract][Full Text] [Related]
12. Occlusive paromomycin for cutaneous leishmaniasis.
Bryceson AD
Lancet; 1997 May; 349(9063):1477. PubMed ID: 9164342
[No Abstract] [Full Text] [Related]
13. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.
Schmidt-Ott R; Klenner T; Overath P; Aebischer T
Trans R Soc Trop Med Hyg; 1999; 93(1):85-90. PubMed ID: 10492799
[TBL] [Abstract][Full Text] [Related]
14. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P
Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.
Ferreira BA; Coser EM; de la Roca S; Aoki JI; Branco N; Soares GHC; Lima MIS; Coelho AC
PLoS Negl Trop Dis; 2024 May; 18(5):e0012175. PubMed ID: 38768213
[TBL] [Abstract][Full Text] [Related]
16. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.
Francesconi VA; Francesconi F; Ramasawmy R; Romero GAS; Alecrim MDGC
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006225. PubMed ID: 29481560
[TBL] [Abstract][Full Text] [Related]
17. [Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Rezzano S; Armas JA; Moreno G; Scorza JV
Acta Cient Venez; 1984; 35(5-6):394-403. PubMed ID: 6537698
[No Abstract] [Full Text] [Related]
18. Cutaneous leishmaniasis due to Leishmania infantum. Case reports and literature review.
del Giudice P; Marty P; Lacour JP; Perrin C; Pratlong F; Haas H; Dellamonica P; Le Fichoux Y
Arch Dermatol; 1998 Feb; 134(2):193-8. PubMed ID: 9487211
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.
van Thiel PP; Leenstra T; de Vries HJ; van der Sluis A; van Gool T; Krull AC; van Vugt M; de Vries PJ; Zeegelaar JE; Bart A; van der Meide WF; Schallig HD; Faber WR; Kager PA
Am J Trop Med Hyg; 2010 Dec; 83(6):1295-300. PubMed ID: 21118937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
